Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019079 (hemoptysis)
 6,129 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The response of 150 patients with pulmonary tuberculosis haemoptysis treated by artificial pneumoperitoneum, when they failed to the regular hemostatic drugs, is analysed. The data showed that 101 cases (67.3%), got favorable results, and there was less effective (24.3%) in 35 patients; only 14 cases (9.3%) failed. Thus the total response rate was 90.6%. The conclusion is that artificial pneumoperitoneum is a rather safe, simple economic and effective method in treatment for hemoptysis of pulmonary to tuberculosis.
Zhonghua Jie He He Hu Xi Za Zhi 1991 Dec
PMID:[Re-estimation on the role of artificial pneumoperitoneum in the treatment of pulmonary tuberculosis haemoptysis]. 181 73

Findings in patients who underwent computed tomography (CT)-guided percutaneous needle biopsy (n = 131) of lung are described. In those in whom the needle traversed aerated lung, complications developed in 51% (40 of 79). The rate of pneumothorax was 46% (36 of 79). In those in whom the needle did not traverse aerated lung (n = 52), minor hemoptysis in one patient (2%) was the only complication (P less than .0001). When a percutaneous CT-guided lung biopsy needle does not traverse aerated lung, the likelihood of complication appears to be slight.
Radiology 1991 Dec
PMID:Complications after CT-guided needle biopsy through aerated versus nonaerated lung. 194 96

Massive hemoptysis due to a recurrent aortobronchial fistula after repair of a thoracic aortic aneurysm developed in a 64-year-old woman. The infected aortic tissue was resected and replaced with an in situ Dacron graft covered by omentum. The patient is alive and well 15 months later.
Ann Thorac Surg 1990 Dec
PMID:Management of aortobronchial fistula with graft replacement and omentopexy. 214 30

A 71-year-old man with a postoperative aortobronchial fistula was successfully treated. The fistula occurred between the left lower lobe and the descending thoracic aorta, to which a distal anastomosis of a temporary bypass graft had been placed during thoracic aortic aneurysmectomy 3 years before. For saving patients with this complication, early surgical treatment during episodes of intermittent hemoptysis is important. The use of an omentum pedicle flap for the isolation of the suture line is a important adjunct.
Ann Thorac Surg 1990 Dec
PMID:Aortobronchial fistula after an aortic operation. 214 31

Post-transfusion purpura is characterized by the occurrence of acute immune thrombocytopenia 5 to 10 days after transfusion of platelet-containing blood products in subjects who had been alloimmunized to specific platelet antigens. Four cases are reported here. Three of these 4 patients, who had a rare PLA1 platelet phenotype, had developed, during a previous sensitization (pregnancy n = 2, transfusion n = 1), an allo antibody directed against PLA1 antigen. The fourth patient presented a specific anti-PLA2 antibody. Thrombocytopenia (platelet count between 4 and 40 x 10(9)/1) appeared 1 to 12 days after the responsible transfusion and showed as haematomas (n = 3) or haemoptysis (n = 1). One patient was asymptomatic and remained untreated. The remaining 3 patients received corticosteroids orally associated, in one case, with infusions of human immunoglobulin concentrates. Thrombocytopenia was corrected within 5 to 13 days. In such cases, whenever another blood transfusion is necessary, a preventive treatment with perfectly platelet-free blood products is mandatory. Platelet depletion by freezing-thawing of red cell concentrates is probably not always sufficient, since recurrence was observed with such a product in one of our patients. The exact cause of immune destruction of autologous platelet remains a mystery.
Presse Med 1990 Dec 15
PMID:[Post-transfusion purpura. An unknown cause of acute immune thrombocytopenia. 4 new cases]. 214 98

A successful removal of the infected thoracic aortic aneurysm ruptured to the lung is reported. A 59-year-old man who had been suffering from high fever showed sudden hemoptysis and shock during antibiotic therapy. Immediately a so-called temporary bypass grafting from ascending aorta to descending aorta was placed with a woven Dacron prosthesis, and then aneurysmectomy with upper lobectomy of the left lung was carried out. Finally the graft was left as a permanent bypass graft. In addition, the left subclavian artery was reconstructed with a EPTFE graft. The patient is now well one year after operation.
Kyobu Geka 1990 Dec
PMID:[Successful management of a ruptured infected aneurysm of the thoracic aorta: report of a case]. 227 77

Desmopressin and vasopressin were used to control massive haemoptysis in a patient with cystic fibrosis. After bolus doses a continuous infusion of vasopressin was maintained for 36 hours and haemoptysis stopped.
Thorax 1990 Dec
PMID:Life threatening haemoptysis in cystic fibrosis: an alternative therapeutic approach. 203 39

A 50-year-old man was given 1.2 million units of intravenous streptokinase 3 hours after the onset of a hyperacute inferior myocardial infarction. He had been treated for pneumonia 4 weeks previously. Five days after thrombolytic therapy, he developed a massive hemoptysis. The implications of this side effect are discussed.
Int J Cardiol 1990 Dec
PMID:Pulmonary hemorrhage following intravenous streptokinase for acute myocardial infarction. 228 99

Pulmonary abnormalities in cystic fibrosis result from the obstruction of small bronchi by highly viscous mucus. Chronic obstructive lung disease and recurrent pulmonary infections result in a typical radiographic pattern later in the disease. Most patients can now be expected to survive into adulthood. The radiologist must make a careful comparison of serial films in order to detect complications early. By far the most important imaging modality is the conventional chest radiograph. CT is more sensitive for detection of structural abnormalities of the lung. Bronchography is a dangerous procedure and can lead to rapid deterioration of lung function. Lung scanning is a very sensitive method for demonstrating regional disturbances of ventilation and may reveal abnormalities earlier than conventional radiographs. In severe hemoptysis, selective bronchial arteriography with embolization of the bleeding vessel can be a life-saving procedure.
Radiologe 1990 Dec
PMID:[Changes in the lungs in mucoviscidosis. Feasibility and advantages of different imaging techniques]. 229 Sep 29

Palliative therapy for previously irradiated patients with symptomatic recurrent endobronchial malignancy is a difficult problem. We have had the opportunity to treat 20 such patients with high dose rate (50-100 rad/min) endobronchial brachytherapy. Eligible patients had received previous high dose thoracic irradiation (TDF greater than or equal to 90), a performance status of greater than or equal to 50, and symptoms caused by a bronchoscopically defined and implantable lesion. The radiation is produced by a small cobalt-60 source (0.7 Ci) remotely afterloaded by cable control. The source is fed into a 4 mm diameter catheter which is placed with bronchoscopic guidance; it may oscillate if necessary to cover the lesion. A dose of 1,000 rad at 1 cm from the source is delivered. We have performed 22 procedures in 20 patients, four following YAG laser debulking. Most had cough, some with hemoptysis. Eight had dyspnea secondary to obstruction and three had obstructive pneumonitis. In 12, symptoms recurred with a mean time to recurrence of 4.3 months (range 1-9 months). Eighteen patients were followed-up and reexamined via bronchoscope 1-2.5 months following the procedure; two were lost to follow-up. All had at least 50 percent clearance of tumor, and six had complete clearance; most regressions were documented on film or videotape. In six, the palliation was durable. The procedure has been well tolerated with no toxicity. We conclude that palliative endobronchial high dose rate brachytherapy is a useful palliative modality in patients with recurrent endobronchial symptomatic carcinoma.
Chest 1985 Dec
PMID:High dose rate intraluminal irradiation in recurrent endobronchial carcinoma. 241 6


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>